ArticleBMC palliative care2025
Development of a quality indicator set for day hospices in Germany - a multi-stage, quality-assured review of German guidelines and quality indicator sets.
Article in BMC palliative care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structures and objectives of day hospices - Design of a logic model.BMC palliative care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundDay hospices are an emerging component of outpatient palliative care in Germany. However, a standardized quality management system utilizing defined quality indicators has not yet been implemented. This study aimed to develop a new set of quality indicators for day hospices.
methodsThrough a multi-phase, quality-assured review, we screened validated quality indicators from German-language S3 guidelines and established quality indicator sets, including the Quality Indicator System for Outpatient Care (QISA) and Outpatient Quality Indicators and Key Figures (AQUIK) based on defined criteria for their relevance to day hospices. Selected indicators were analyzed by a validated and operationalized evaluation tool (QUALIFY) for their applicability to day hospices by an expert panel and subsequently finalized through a nominal group process.
resultsA total of 19 quality indicators, suitable for quality assurance of day hospices were identified from 482 potential quality indicators drawn from 29 S3 guidelines and 11 quality indicator sets. Of these, 13 indicators pertained to process quality, while 6 addressed structural quality. Indicators for the outcome quality were either not available or not suitable for a day hospice. The 463 not selected indicators were excluded mainly due to possible mismanagement or lack of reference to the goals and tasks of a day hospice.
conclusionsThe newly developed quality indicator set provides a robust framework for assessing and comparing the quality of care in German day hospices. Nevertheless, ongoing refinement and practical evaluation are necessary to ensure its relevance and effectiveness in routine clinical settings.
trial registrationThe study was registered as part of the IMPULS-Study in the German Register of Clinical Studies (DRKS-ID: DRKS00031613; Date of registration: 04 April 2023) and the Display portal of the Center for Clinical Studies of the University Hospital Regensburg (Z-2022-1734-6; Date of registration: 01 October 2022).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.